Immunoregulatory effects of treatment with mesenchymal stem cells on T-cell activity in cirrhosis
Cellule souche mésenchymateuse (MSC) thérapie’s immunomodulatory impact on T-cell activity in cirrhosis is analyzed. This article explores how MSC treatment modifies T-cell responses, potentially offering novel therapeutic strategies for managing cirrhosis-related immune dysfunction. {CONTENU} reveals key findings.




